REG - Craneware plc - Director's Acquisition of Shares

CranewareAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260304:nRSD2053Va&default-theme=true

RNS Number : 2053V  Craneware plc  04 March 2026

Craneware plc

("Craneware" or the "Company")

 

Director's Acquisition of Shares

Notification of Major Holdings and Exercise of Share Options

 

4 March 2026 - The Board of Craneware plc (AIM: CRW.L), a leader in healthcare
financial performance solutions, announces that on 2 March 2026, Keith
Neilson, CEO of the Company, received 28,628 ordinary shares of 1p each in the
Company ("Ordinary Shares") following the exercise of options over 28,628
Ordinary Shares, at an exercise price of 750 pence per Ordinary Share.

Mr. Neilson has chosen to retain the full quantity of shares from the exercise
of share options rather than utilising the Company's net settlement facility
to settle the exercise cost, income tax and national insurance contributions.
These represent a total cost to Mr. Neilson of over £326,000 to retain the
full award.

 

As a result, following the exercise of these share options, Mr. Neilson's
shareholding in the Company has increased to 3,214,471 Ordinary Shares in the
capital of the Company, representing 9.05% of the Company's issued share
capital (excluding 31,700 Ordinary Shares held in treasury).

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:

 

1.   Details of the Restricted Person / person closely associated with him
or her

a)
Name
Keith Neilson

 

2.   Reason for the notification

a) Position /
status
CEO

b) Initial notification /
Amendment                       Initial notification

 

3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)
Name
Craneware plc

b)
LEI
213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument
Ordinary Shares of 1p each in the capital of Craneware plc

 

b) Identification
code
ISIN GB00B2425G68

 

c) Nature of the
transaction
Exercise of options over Ordinary Shares

 

d) Price(s) and
volume(s)
Volume(s) 28,628, Price(s) £7.50

 

e) Aggregated
information:

                                    i.
Aggregated volume                28,628

 

                                    ii.
Price
£7.50

 

 

f) Date of the transaction
           2026-03-02

 

g) Place of the
transaction
Outside a trading venue

 

 

 

For further information, please contact:

 Craneware plc                                     +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications                     +44 (0)20 3405 0205
 Caroline Forde, Kinvara Verdon, Louisa El-Ahwal   craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)                +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 Investec Bank PLC (Joint Broker)                  +44 (0)20 7597 5970
 Patrick Robb, Virginia Bull, Arnav Kapoor
 ( )                                               ( )
 Berenberg (Joint Broker)                          +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Patrick Dolaghan

 

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus® cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHVXLFBQXLLBBV



            Copyright 2019 Regulatory News Service, all rights reserved